10925096

Source:http://linkedlifedata.com/resource/pubmed/id/10925096

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0034897, umls-concept:C0035647, umls-concept:C0194810, umls-concept:C0205474, umls-concept:C0220825, umls-concept:C0279025, umls-concept:C0332152, umls-concept:C0443252, umls-concept:C0600558, umls-concept:C1522577
pubmed:issue	2
pubmed:dateCreated	2000-8-14
pubmed:abstractText	To assess the effects of 8 months of neoadjuvant therapy on pathologic stage and biochemical recurrence rates.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0366151
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Androgen Antagonists, http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, Hormonal, http://linkedlifedata.com/resource/pubmed/chemical/Cyproterone Acetate, http://linkedlifedata.com/resource/pubmed/chemical/Diethylstilbestrol, http://linkedlifedata.com/resource/pubmed/chemical/Flutamide, http://linkedlifedata.com/resource/pubmed/chemical/Leuprolide
pubmed:status	MEDLINE
pubmed:month	Aug
pubmed:issn	1527-9995
pubmed:author	pubmed-author:BruchovskyNN, pubmed-author:GleaveM EME, pubmed-author:GoldenbergS LSL, pubmed-author:JonesE CEC, pubmed-author:La BiancaS ESE, pubmed-author:SullivanL DLD
pubmed:issnType	Electronic
pubmed:day	1
pubmed:volume	56
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	289-94
pubmed:dateRevised	2004-11-17
pubmed:meshHeading	pubmed-meshheading:10925096-Adult, pubmed-meshheading:10925096-Aged, pubmed-meshheading:10925096-Androgen Antagonists, pubmed-meshheading:10925096-Antineoplastic Agents, Hormonal, pubmed-meshheading:10925096-Combined Modality Therapy, pubmed-meshheading:10925096-Cyproterone Acetate, pubmed-meshheading:10925096-Diethylstilbestrol, pubmed-meshheading:10925096-Drug Therapy, Combination, pubmed-meshheading:10925096-Flutamide, pubmed-meshheading:10925096-Follow-Up Studies, pubmed-meshheading:10925096-Humans, pubmed-meshheading:10925096-Leuprolide, pubmed-meshheading:10925096-Lymph Node Excision, pubmed-meshheading:10925096-Male, pubmed-meshheading:10925096-Middle Aged, pubmed-meshheading:10925096-Neoadjuvant Therapy, pubmed-meshheading:10925096-Postoperative Complications, pubmed-meshheading:10925096-Prostatectomy, pubmed-meshheading:10925096-Prostatic Neoplasms, pubmed-meshheading:10925096-Recurrence, pubmed-meshheading:10925096-Treatment Outcome
pubmed:year	2000
pubmed:articleTitle	Long-term neoadjuvant hormone therapy prior to radical prostatectomy: evaluation of risk for biochemical recurrence at 5-year follow-up.
pubmed:affiliation	Division of Urology, University of British Columbia, Vancouver General Hospital, Vancouver, British Columbia, Canada.
pubmed:publicationType	Journal Article